Key points

  • Robinhood CEO Vlad Tenev said issuers should control rights attached to their shares, but not every separate product that references those shares.
  • Robinhood describes its stock tokens as debt securities providing economic exposure, not direct ownership or conventional shareholder rights.
  • AMC has demanded that Robinhood stop offering AMC-linked tokens and has said it plans to raise its concerns with the U.S. SEC.

Robinhood CEO Vlad Tenev has expanded his defense of tokenized stock products after AMC Entertainment objected to a token linked to its shares. In a September 11 post, Tenev argued that public companies should control the rights attached to their own shares, but should not automatically receive a veto over separate financial products that reference freely traded stock.

The dispute is about legal rights, not just blockchain

Tenev drew a boundary between products that track shares and products that change them. He said an issuer should be involved if a token alters shareholder rights, replaces the company's official stock ledger or creates new obligations for the company or its transfer agent. By contrast, he argued that issuer approval should not be required for a separate instrument that holds or references shares without changing the authoritative ownership record.

Related reporting: Robinhood rejects issuer veto over AMC-linked stock tokens

That distinction is central to Robinhood's model. Its documentation describes Stock Tokens as tokenized debt securities issued by Robinhood Assets (Jersey) Limited. The products aim to provide economic exposure to an underlying security, but token holders do not become direct owners of the referenced shares and do not receive rights against the company that issued those shares. The offering is not available to U.S. customers.

AMC says the structure can confuse investors

AMC CEO Adam Aron has taken the opposite view. In public posts beginning September 3, he said AMC had no role in or endorsement of Robinhood's AMC-linked token. He later demanded that Robinhood halt the product and said the cinema operator would consult securities counsel and raise the matter with the U.S. Securities and Exchange Commission. No SEC action has been announced in connection with the dispute.

Aron's concerns include whether customers understand that the token is not an AMC share, whether a parallel market can diverge from the listed stock, and whether products using a company's name can affect confidence in conventional capital raising. Robinhood says the structure is comparable in principle to other lawful instruments, such as options or structured products, that can reference a public company's shares without being issued by that company.

Why the distinction matters to buyers

For investors, the label 'stock token' does not by itself establish what they own. A blockchain instrument can represent a direct share, a custodially backed claim or a synthetic exposure issued by another entity. Those structures can differ in voting rights, dividend treatment, redemption, counterparty risk, trading hours and the process for handling corporate actions. The relevant disclosure and governing law therefore matter as much as the underlying technology.

Robinhood says its products are backed one-for-one by underlying shares, while its documentation identifies the Jersey entity as the token issuer. That means the legal claim runs through Robinhood's product structure rather than placing the holder on AMC's shareholder register. Tenev said buyers should be told what they own, what rights it carries and whether the referenced company is involved.

A test for wider equity tokenization

The argument extends beyond the two companies. Crypto firms, brokerages and traditional exchanges are developing different routes for putting equity exposure on blockchain networks. Issuer-sponsored models emphasize direct participation and shareholder rights, while third-party models prioritize broad distribution and the ability to add assets without negotiating with every company.

The unresolved questions are regulatory and practical: how clearly products must be labeled, what protections apply across jurisdictions, how closely token prices track the underlying shares and whether issuers have any legal power to object. AMC's threatened referral does not establish that Robinhood violated U.S. law, and Tenev's defense does not settle how regulators will treat similar products. The dispute is instead a live test of where control over a public share ends and control over a product referencing it begins.

Sources

AI-generated editorial image; not a photograph of the reported event. Prepared with AI assistance and source verification.